GLADIATOR FOR MEN
LIVE

Serial Number

98382414

Owner

creative medical technologies inc.

Attorney

Marc Baumgartner

Filing Date

Jan 30, 2024

Add to watchlist:

No watchlists yet
View on USPTO

GLADIATOR FOR MEN Trademark

Serial Number: 98382414

GLADIATOR FOR MEN is a trademark filed by creative medical technologies inc. on January 30, 2024. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

creative medical technologies inc.

3008 W Lupine Ave
Phoenix, AZ 85029

Entity Type: 03

Trademark Details

Filing Date

January 30, 2024

Registration Date

Not Registered

Published for Opposition

July 9, 2024

Goods & Services

Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of a coating for sublingual wafers that facilitate the delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of edible wafers for wrapping powdered pharmaceuticals; Drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of sublingual wafers that facilitate the delivery of pharmaceutical preparations; Drug testing kits comprised of medical diagnostic reagents and assays for testing body fluids; Implantable subcutaneous drug delivery devices sold filled with pharmaceutical preparations for treating erectile dysfunction; Pharmaceutical preparations for inducing erections; Stem cells for medical purposes; Pharmaceutical for the treatment of erectile dysfunction; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 4, 2026 EXRA
SOU EXTENSION 3 GRANTED
Mar 3, 2026 EX3G
SOU EXTENSION 3 FILED
Mar 3, 2026 EXT3
SOU TEAS EXTENSION RECEIVED
Mar 3, 2026 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 15, 2025 EXRA
SOU EXTENSION 2 GRANTED
Sep 3, 2025 EX2G
SOU EXTENSION 2 FILED
Sep 3, 2025 EXT2
SOU TEAS EXTENSION RECEIVED
Sep 3, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 16, 2025 EXRA
SOU EXTENSION 1 GRANTED
May 15, 2025 EX1G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
May 12, 2025 AITU
SOU EXTENSION RECEIVED WITH TEAS PETITION
Mar 4, 2025 TPEX
NOTICE OF REVIVAL - E-MAILED
Mar 4, 2025 NREV
PETITION TO REVIVE-GRANTED
Mar 4, 2025 PETG
TEAS PETITION TO REVIVE RECEIVED
Mar 4, 2025 PROA
SOU EXTENSION 1 FILED
Mar 2, 2025 EXT1
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sep 3, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 9, 2024 NPUB
PUBLISHED FOR OPPOSITION
Jul 9, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 19, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 4, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 4, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 4, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 4, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 3, 2024 GNRN
NON-FINAL ACTION E-MAILED
Jun 3, 2024 GNRT
NON-FINAL ACTION WRITTEN
Jun 3, 2024 CNRT
ASSIGNED TO EXAMINER
May 30, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 29, 2024 NWOS
NEW APPLICATION ENTERED
Jan 30, 2024 NWAP